These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 18855271

  • 1. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
    Rubio-Guerra AF, Vargas-Robles H, Vargas-Ayala G, Rodriguez-Lopez L, Escalante-Acosta BA.
    Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
    [Abstract] [Full Text] [Related]

  • 2. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
    Rubio-Guerra AF, Vargas-Robles H, Vargas-Ayala G, Rodríguez-Lopez L, Castro-Serna D, Escalante-Acosta BA.
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
    [Abstract] [Full Text] [Related]

  • 3. Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients.
    Rubio-Guerra AF, Vargas-Robles H, Lozano Nuevo JJ, Escalante-Acosta BA.
    Kidney Blood Press Res; 2009 Aug; 32(2):106-9. PubMed ID: 19342863
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J, Dzúrik R.
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G, BENEDICT Study Group.
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H, Midorikawa S, Yatabe J, Yatabe MS, Katoh T, Baba T, Hashimoto S, Watanabe T.
    Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
    [Abstract] [Full Text] [Related]

  • 12. Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients.
    Rubio-Guerra AF, Vargas-Robles H, Ayala GV, Escalante-Acosta BA.
    Med Sci Monit; 2007 Aug; 13(8):CR349-52. PubMed ID: 17660723
    [Abstract] [Full Text] [Related]

  • 13. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R, Puig JG, Rodríguez-Pérez JC, Garrido J, Redon J, TRAVEND Study Group.
    J Hum Hypertens; 2001 Dec; 15(12):849-56. PubMed ID: 11773987
    [Abstract] [Full Text] [Related]

  • 14. [Adhesion molecules in type 2 diabetes].
    Sokup A.
    Przegl Lek; 2005 Dec; 62(4):234-7. PubMed ID: 16229242
    [Abstract] [Full Text] [Related]

  • 15. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
    Rubio-Guerra AF, Arceo-Navarro A, Vargas-Ayala G, Rodriguez-Lopez L, Lozano-Nuevo JJ, Gomez-Harper CT.
    Diabetes Care; 2004 Jul; 27(7):1688-91. PubMed ID: 15220247
    [Abstract] [Full Text] [Related]

  • 16. Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus.
    Rizzoni D, Muiesan ML, Porteri E, Castellano M, Salvetti M, Monteduro C, De Ciuceis C, Boari G, Valentini U, Cimino A, Sleiman I, Agabiti-Rosei E.
    J Hum Hypertens; 2003 Jul; 17(7):463-70. PubMed ID: 12821953
    [Abstract] [Full Text] [Related]

  • 17. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
    Turhan H, Saydam GS, Erbay AR, Ayaz S, Yasar AS, Aksoy Y, Basar N, Yetkin E.
    Int J Cardiol; 2006 Apr 04; 108(2):224-30. PubMed ID: 16002164
    [Abstract] [Full Text] [Related]

  • 18. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.
    Boulbou MS, Koukoulis GN, Vasiou KG, Petinaki EA, Gourgoulianis KI, Fezoulidis IB.
    Int Angiol; 2004 Mar 04; 23(1):18-24. PubMed ID: 15156125
    [Abstract] [Full Text] [Related]

  • 19. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C, Heintz B, Sieberth HG.
    Clin Nephrol; 1999 Nov 04; 52(5):312-21. PubMed ID: 10584995
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control.
    Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD.
    Thromb Haemost; 1994 Dec 04; 72(6):979-84. PubMed ID: 7537916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.